🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Spinal Mobility, Rigidity, and Kinesiophobia in PD and TMD

Recruitingn/aAges 35 Years - 75 YearsAllMustafa Kemal University
NCT07850674 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Axial rigidity and loss of spinal mobility commonly observed in Parkinson's disease (PD) lead to postural deformities and substantial reductions in trunk flexibility. This condition can impair the biomechanics of the craniocervical and lumbopelvic kinetic chain, potentially exerting a negative impact on temporomandibular joint (TMJ) functions. In this context, the planned study aims to determine whether differences exist in spinal mobility, axial rigidity, and kinesiophobia levels between individuals with PD with and without Temporomandibular Disorders (TMD), and to investigate whether a biomechanical relationship exists between TMD and spinal mobility, axial rigidity, and kinesiophobia levels in this population. The study will be conducted face-to-face at the Neurology Outpatient Clinic of Hatay Mustafa Kemal University Research and Training Hospital. Individuals aged 40-75 years, diag

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Diagnosed with Parkinson's disease * Modified Hoehn \& Yahr stages 1.5 to 4 * Mini-Mental State Examination (MMSE) score ≥ 24 * Evaluated during the medication "ON" state Exclusion Criteria: * History of cervical, lumbar, maxillofacial, or temporomandibular joint surgery -Acute orthopedic or severe rheumatologic disease (e.g., advanced ankylosing spondylitis) * Additional comorbid neurological disorders (e.g., stroke, multiple sclerosis) * Complete edentulism or severe disruption of oral anatomy * Ongoing acute dental pain * Pregnancy or suspected pregnancy * Severe psychiatric disorders
💊

What it tests

  • Not listed
📍

Where

1 site
Hatay Mustafa Kemal Universty
Hatay, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy